The global GLP-1 market size is likely to grow from USD 49.3 billion in 2024 to USD 157.5 billion by 2035, growing at a CAGR of 11.1% during the forecast period, till 2035.
Rise in demand of glp-1 drugs for metabolic disorders.In recent years, owing to its broader clinical potential in the treatment of obesity and type 2 diabetes, along with their proven efficacy in reducing cardiovascular risks, GLP-1 drugs market has garnered significant traction within the medical science domain. Concurrently, the rising demand and escalating prevalence of metabolic disorder including type 2 diabetes and obesity are fueling the need for treatments capable of effectively managing these conditions. This trend is expected to drive innovation and stimulate market growth within this sector.
Distribution by Active Compound Used
• Dulaglutide
• Liraglutide
• Orforglipron
• Retatrutide
• Semaglutide
Distribution by Type of Agonist
• Single agonist
• Dual agonist
• Tri-agonist
Distribution by Target Indication
• Alzheimer’s Disease
• Non-Alcoholic Steatohepatitis
• Obesity
• Sleep Apnea
• Type 2 Diabetes
Distribution by Route of Administration
• Oral
• Parenteral
Key Geographical Regions
• North America
• Europe
• Asia-Pacific
• Latin America
Key players
• AstraZeneca
• Biolingus
• Boehringer Ingelheim
• D&D Pharmatech
• Eli Lilly
• Gmax Biopharm
• Hanmi Pharmaceutical
• Innogen
• Novo Nordisk
• PegBio
• Pfizer
Over the years, rise in the demand of GLP-1 drugs has increased the research activity in this domain. The rich pipeline of GLP-1 drugs is also driving growth in the GLP-1 market, as the conditions like obesity is on the rise, more patients and doctors are looking for treatment options. As the market climbs higher, addressing issues of cost and availability will be essential in making sure that the advantages of GLP-1 medications are accessible to a broader group of people. With ongoing research and development, we anticipate further progress in this area, leading to a new period of managing metabolic conditions.
Research Methodology
Our analysts have performed an accurate examination of the various aspects of the global market leveraging avant-garde primary and secondary sources of data collection. The report has gathered the necessary data and information from several reliable sources. Additionally, the report offers many strategic recommendations for companies involved in this ever-growing business sector to help them attain a competitive edge in the GLP-1 Market.
Thank you for reading our report. Kindly get in touch with us to know more about the report or to receive a customized copy of it. Our team will ensure the report is tailored according to your needs.
To get sample report visit@
https://www.rootsanalysis.com/reports/g ... ample.html